These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14676438)

  • 1. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
    Kang MJ; Oh YM; Lee JC; Kim DG; Park MJ; Lee MG; Hyun IG; Han SK; Shim YS; Jung KS
    J Korean Med Sci; 2003 Dec; 18(6):821-7. PubMed ID: 14676438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.
    Vignola AM; Riccobono L; Mirabella A; Profita M; Chanez P; Bellia V; Mautino G; D'accardi P; Bousquet J; Bonsignore G
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1945-50. PubMed ID: 9847290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
    Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
    Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model.
    Sun J; Bao J; Shi Y; Zhang B; Yuan L; Li J; Zhang L; Sun M; Zhang L; Sun W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():717-724. PubMed ID: 28260878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
    Beeh KM; Beier J; Kornmann O; Buhl R
    Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of correlation between pulmonary function and expression levels of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinase-1 among toluene diisocyanate exposed workers].
    Miao PP; Meng T; Jia Q; Niu Y; Ye M; Ji YQ; Ju R; Chen XL; Shao H; Zheng YX; Dai YF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):418-22. PubMed ID: 27141897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD.
    Yao H; Hwang JW; Sundar IK; Friedman AE; McBurney MW; Guarente L; Gu W; Kinnula VL; Rahman I
    Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(9):L615-24. PubMed ID: 24039251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
    Papakonstantinou E; Karakiulakis G; Batzios S; Savic S; Roth M; Tamm M; Stolz D
    Respir Res; 2015 Jun; 16(1):78. PubMed ID: 26126526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of N-acetylcysteine on the cytokines and matrix metalloproteinases in chronic obstructive pulmonary disease rat models].
    Xu L; Cai BQ; Zhu YJ; Guo ZJ; Zhang H; Gu L; Xu XX
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):595-9. PubMed ID: 15355665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD; Kapsner RK; Osberg I
    Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
    Higashimoto Y; Yamagata Y; Iwata T; Okada M; Ishiguchi T; Sato H; Masuda M; Itoh H
    Eur Respir J; 2005 May; 25(5):885-90. PubMed ID: 15863647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
    Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
    Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications.
    Mocchegiani E; Giacconi R; Costarelli L
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S11-9. PubMed ID: 22209925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.